Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Nov;22(5):513–520. doi: 10.1111/j.1365-2125.1986.tb02929.x

Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?

U Klotz, G Ziegler, B Rosenkranz, G Mikus
PMCID: PMC1401171  PMID: 3098270

Abstract

Ethanol aggravates benzodiazepine-induced central nervous depression by pharmacokinetic and/or pharmacodynamic interactions and Ro 15-1788 reverses promptly the hypnotic effects of benzodiazepines. We therefore studied the acute effects of Ro 15-1788 on the ethanol-induced sedation in six healthy male subjects. Subsequently to an oral loading dose (0.54 g ethanol kg-1) ethanol was infused for 4 h (0.15 g ethanol kg-1 h-1) and steady state blood levels between 0.9 to 1.2 g l-1 were reached within 2 h. At steady state and during the elimination phase of ethanol an intravenous bolus of 0.5 mg Ro 15-1788 or placebo was administered in a randomized, double-blind crossover fashion. The marked sedative effects of ethanol as assessed by visual analogue scales (2 to 6 fold increase in the sedation index), and choice reaction time (25 to 40% prolongation) were not affected by Ro 15-1788. However, the pharmaco-EEG indicated that Ro 15-1788 seems to reverse transiently the ethanol-induced changes in total alpha, delta, and slow alpha bands. There was no pharmacokinetic interaction between both agents since elimination of Ro 15-1788 (t1/2 = 1.2 +/- 0.7 h) and of ethanol (0.17 +/- 0.02 g l-1 h-1) were in good agreement with control values. Thus, it could be concluded that Ro 15-1788 might affect for a short while the action of ethanol by interfering with the benzodiazepine receptors.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett J. E., Brady L. S., Witkin J. M. Behavioral studies with anxiolytic drugs. I. Interactions of the benzodiazepine antagonist Ro 15-1788 with chlordiazepoxide, pentobarbital and ethanol. J Pharmacol Exp Ther. 1985 Jun;233(3):554–559. [PubMed] [Google Scholar]
  2. Burch T. P., Ticku M. K. Ethanol enhances [3H]diazepam binding at the benzodiazepine-GABA-receptor-ionophore complex. Eur J Pharmacol. 1980 Oct 17;67(2-3):325–326. doi: 10.1016/0014-2999(80)90519-1. [DOI] [PubMed] [Google Scholar]
  3. Darragh A., Lambe R., Kenny M., Brick I., Taaffe W., O'Boyle C. RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability. Br J Clin Pharmacol. 1982 Nov;14(5):677–682. doi: 10.1111/j.1365-2125.1982.tb04956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Darragh A., Lambe R., Scully M., Brick I., O'Boyle C., Downe W. W. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788. Lancet. 1981 Jul 4;2(8236):8–10. doi: 10.1016/s0140-6736(81)90251-8. [DOI] [PubMed] [Google Scholar]
  5. Dorow R., Horowski R., Paschelke G., Amin M. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet. 1983 Jul 9;2(8341):98–99. doi: 10.1016/s0140-6736(83)90076-4. [DOI] [PubMed] [Google Scholar]
  6. Gaillard J. M., Blois R. Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes. Br J Clin Pharmacol. 1983 May;15(5):529–536. doi: 10.1111/j.1365-2125.1983.tb02086.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holford N. H., Sheiner L. B. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981 Nov-Dec;6(6):429–453. doi: 10.2165/00003088-198106060-00002. [DOI] [PubMed] [Google Scholar]
  8. Kemperman C. J. beta-Carbolines, alcohol, and depression. Lancet. 1983 Jan 15;1(8316):124–125. doi: 10.1016/s0140-6736(83)91765-8. [DOI] [PubMed] [Google Scholar]
  9. Klotz U., Duka T., Dorow R., Doenicke A. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788. Br J Clin Pharmacol. 1985 Jan;19(1):95–98. doi: 10.1111/j.1365-2125.1985.tb02619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klotz U., Ziegler G., Ludwig L., Reimann I. W. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans. J Clin Pharmacol. 1985 Sep;25(6):400–406. doi: 10.1002/j.1552-4604.1985.tb02866.x. [DOI] [PubMed] [Google Scholar]
  11. Klotz U., Ziegler G., Reimann I. W. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol. 1984;27(1):115–117. [PubMed] [Google Scholar]
  12. Liljequist S., Engel J. A. The effects of GABA and benzodiazepine receptor antagonists on the anti-conflict actions of diazepam or ethanol. Pharmacol Biochem Behav. 1984 Oct;21(4):521–525. doi: 10.1016/s0091-3057(84)80033-7. [DOI] [PubMed] [Google Scholar]
  13. Polc P., Bonetti E. P., Schaffner R., Haefely W. A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone. Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(4):260–264. doi: 10.1007/BF00498510. [DOI] [PubMed] [Google Scholar]
  14. Radlow R., Hurst P. M. Temporal relations between blood alcohol concentration and alcohol effect: an experiment with human subjects. Psychopharmacology (Berl) 1985;85(3):260–266. doi: 10.1007/BF00428184. [DOI] [PubMed] [Google Scholar]
  15. Rangno R. E., Kreeft J. H., Sitar D. S. Ethanol 'dose-dependent' elimination: Michaelis-Menten v classical kinetic analysis. Br J Clin Pharmacol. 1981 Nov;12(5):667–673. doi: 10.1111/j.1365-2125.1981.tb01287.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schöpf J., Laurian S., Le P. K., Gaillard J. M. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation. Pharmacopsychiatry. 1984 May;17(3):79–83. doi: 10.1055/s-2007-1017413. [DOI] [PubMed] [Google Scholar]
  17. Van Gorder P. N., Hoffman W. E., Baughman V., Albrecht R. F., Miletich D. J., Guzman F., Cook J. M. Midazolam-ethanol interactions and reversal with a benzodiazepine antagonist. Anesth Analg. 1985 Feb;64(2):129–135. [PubMed] [Google Scholar]
  18. Ziegler G., Ludwig L., Fritz G. Reversal of slow-wave sleep by benzodiazepine antagonist Ro 15-1788. Lancet. 1985 Aug 31;2(8453):510–510. doi: 10.1016/s0140-6736(85)90452-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES